Elizabeth G. Ingram is on the board of Avenue Therapeutics, Inc. and President & Chief Executive Officer for Cipla Therapeutics, Inc.

In the past Ms. Ingram occupied the position of Vice President-Market Access Strategy at Bristol Myers Squibb Co., Senior Vice President-Managed Market at DexCom, Inc. and Chief Marketing Officer of MannKind Corp.

Elizabeth G. Ingram received an undergraduate degree from East Carolina University and a graduate degree from the University of South Carolina.